Meet the six finalists in the Ascensia Diabetes Challenge, a global innovation competition designed to find digital solutions to transform Type 2 diabetes management.
Arda Ural of Ernst and Young says there are favorable conditions going on in the medtech industry that could help lead to more acquisitions in the space.
Prescient Medical developed CleanCision, an active cleansing technology used to prevent surgical infections.
If Stryker is, in fact, making a play for Boston Scientific, will Johnson & Johnson enter the fray if a bidding war emerges? Analysts say the chances are pretty good.
An industry expert talks about new autoinjector designs that can address the specific wants and needs of individual patients.
Designers of wearable health devices will walk the catwalk at MD&M East to showcase the products that are enabling new capabilities in mobile healthcare, with a focus on prevention, screening, and disease management.
Bluetooth technology may be the gold standard in connected health, but what about the pitfalls? One diabetes management company argues that cell-enabled technology is the way to go.
ThinkGenetic’s co-founder and CEO is set to moderate panel at MD&M East and discuss how artificial intelligence is growing in healthcare and helping to redefine the medtech space.
By understanding a medical device’s intended use case and environment, designers can pursue opportunities without complicating requirements documentation.
The Centers for Medicare & Medicaid Services has agreed to reconsider coverage for LivaNova's Vagus Nerve Stimulation device for treatment-resistant depression. What is the most likely outcome of this process?
An industry expert explains the impact new battery technologies are having on emerging medtech applications, and how to match the right battery to your device.
The rapid evolution of medtech has left many aspects of the industry scrambling to keep up, including its business ethics.